SARS-Cov-2 Process Control - Pellets
The product allows laboratories to validate the entire process of a molecular assay including extraction, reverse transcription, amplification, and detection. It is nuclease resistant and can be spiked into nuclease-rich patient samples such as nasal secretions or plasma.
Each kit contains 6 individually packaged lyophilized pellets.
Biosafety Level:
1
Product Format:
Helix Elite Synthetic Standard
Strain Characteristics:
The SARS-CoV-2 Process Control (Pellet) is made with RNA transcripts containing diagnostically relevant targets (CDC and WHO consensus sequences) encapsulated in a phage protein.
Includes human respiratory epithelial cells.
Nucleotides contained in each pellet (All positions in reference to GenBank Acc. NC_045512.2)
Orf1ab / RdRP: 12,690 ..12,797 | 13,342 ..13,460 | 14,080 ..14,186 | 15,431 ..15,530
S (Spike): 18,778 ..18,909 | 24,354 ..24,900
E (Envelope): 26,245 ..26,427 | 26,269 ..26,381
N (Nucleocapsid): 28,237 ..29,280
Internal Reference:
GEN - R9000
Website URL:
/shop/gen-r9000-sars-cov-2-process-control-pellets-507422
Your Dynamic Snippet will be displayed here...
This message is displayed because youy did not provide both a filter and a template to use.
Our Products !
Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.